R&F Capital Advisors LP - PHARMATHENE INC ownership

PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 73 filers reported holding PHARMATHENE INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
R&F Capital Advisors LP ownership history of PHARMATHENE INC
ValueSharesWeighting
Q4 2016$74,00022,7010.03%
Other shareholders
PHARMATHENE INC shareholders Q1 2017
NameSharesValueWeighting ↓
Northern Right Capital Management, L.P. 1,328,108$4,316,0004.41%
PERKINS CAPITAL MANAGEMENT INC 708,100$2,301,0002.52%
PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. 3,262,422$10,603,0002.23%
Nantahala Capital Management 3,202,045$10,407,0001.08%
TFS CAPITAL LLC 453,016$1,472,0000.39%
Teza Capital Management LLC 34,000$110,0000.15%
Acrospire Investment Management LLC 58,081$189,0000.08%
ALPINE WOODS CAPITAL INVESTORS, LLC 414,816$1,348,0000.07%
TWO SIGMA SECURITIES, LLC 55,733$181,0000.06%
OXFORD ASSET MANAGEMENT LLP 526,066$1,710,0000.06%
View complete list of PHARMATHENE INC shareholders